Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System

Diana van Stijn1, Annemarie Slegers1, Hans Zaaijer2

  • 1Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Frontiers in Pediatrics
|February 15, 2021
PubMed

Insights

Children with Kawasaki disease (KD) show lower rates of prior cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections. This suggests an under-challenged immune system may increase KD susceptibility.

Area of Science:

  • Pediatric immunology
  • Infectious diseases
  • Vascular inflammation

Background:

  • Kawasaki disease (KD) is a pediatric vasculitis with unknown causes.
  • Genetic predisposition and exposure to pathogens are suspected triggers.
  • Early-life immune status may influence KD development.

Purpose of the Study:

  • To investigate the association between prior cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections and Kawasaki disease (KD).
  • To test the hypothesis that early systemic immune responses may protect against KD.

Main Methods:

  • Comparison of CMV and EBV VCA IgG seroprevalence in 86 KD patients versus age-matched healthy controls.
  • Serological testing performed before or 9 months after intravenous immunoglobulin (IVIG) treatment.

Main Results:

  • KD patients exhibited an approximately 2-fold lower seroprevalence for both CMV and EBV compared to controls.
  • This indicates a potential difference in past viral exposure or immune response.

Conclusions:

  • An under-challenged immune system might lead to altered immune reactivity in children.
  • This altered reactivity could influence the response to triggers, potentially contributing to KD development in susceptible individuals.